SHC (Sotera Health Co) Ending Cash Position: $316 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHC Sotera Health Co SHC
74 GF Score
Price $17.75
GF Value $16.36
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Sotera Health Co Ending Cash Position?

Sotera Health Co SHC -2.85% 74 Ending Cash Position is $316 Mil as of Mar. 2026. GuruFocus rates SHC with a GF Score™ of 74/100 and a GF Value™ of $16.36 (Fairly Valued). The stock has 5 warning signs investors should review.

Sotera Health Co's Ending Cash Position for the quarter that ended in Mar. 2026 was $316 Mil.

Sotera Health Co's quarterly Ending Cash Position increased from Sep. 2025 ($301 Mil) to Dec. 2025 ($346 Mil) but then declined from Dec. 2025 ($346 Mil) to Mar. 2026 ($316 Mil).

Sotera Health Co's annual Ending Cash Position declined from Dec. 2023 ($302 Mil) to Dec. 2024 ($279 Mil) but then increased from Dec. 2024 ($279 Mil) to Dec. 2025 ($346 Mil).

Sotera Health Co Ending Cash Position Related Terms

Sotera Health Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Sotera Health Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sotera Health Co Ending Cash Position Chart

Sotera Health Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 106.92 396.29 301.65 278.87 346.46

Sotera Health Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 306.08 334.27 301.03 346.46 315.95
SHC
74GF Score
Sotera Health Co SHC
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sotera Health Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sotera Health Co's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=278.865+67.591
=346

Sotera Health Co's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=346.456+-30.511
=316

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $316 Mil mean?
Sotera Health Co (SHC) has a Ending Cash Position of $316 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Sotera Health Co and its competitors.
Is Sotera Health Co's Ending Cash Position too high?
Sotera Health Co's current Ending Cash Position is $316 Mil. Overall, Sotera Health Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's Ending Cash Position compare to VCYT and RDNT?
Sotera Health Co's Ending Cash Position of $316 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Diagnostics & Research company?
A good Ending Cash Position depends on the Medical Diagnostics & Research industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Sotera Health Co and its competitors. Sotera Health Co's current Ending Cash Position is $316 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Fairly Valued. The stock's GF Value™ is $16.36, compared to a current price of $17.75 — trading 8.5% above its estimated fair value. The current Ending Cash Position is $316 Mil. Sotera Health Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Sotera Health Co (SHC), the current Ending Cash Position is $316 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sotera Health Co (SHC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued. The current stock price of $17.75 is trading 8.5% above its estimated GF Value™ of $16.36. GuruFocus considers Sotera Health Co to be Fairly Valued.

Key valuation signals for SHC:

  • Ending Cash Position: $316 Mil
  • GF Value™: $16.36 vs. price of $17.75 (8.5% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sotera Health Co Business Description

Address 9100 South Hills Boulevard, Suite 300, Broadview Heights, OH, USA, 44147
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
74GF Score

Get the complete analysis for SHC

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.75
Price
$16.36
GF Value